None listed
Conditions
Interventions
Drug : Randomization and drug administration
Of 184 patients, 92 patients were randomly assigned to CleanViewAL acid and Ora-Fang tablets. In the case of the morning test, the CleanViewAL acid group p
Sponsors
Asan Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients who visited the hospital for screening colonoscopy for colon cancer screening 2) Patients who visited the hospital for diagnosis colonoscopy due to non-specific abdominal discomfort 3) Patients who visited the hospital for colonoscopy treatment such as polypectomy
Exclusion criteria
Exclusion criteria: 1) Male or female under the age of 18 2) Patients with chronic bowel disease, including inflammatory bowel disease 3) Patients with massive bloody stool 4) Patients with renal dysfunction 5) Patients for the purpose of follow-up after colon cancer surgery and pre-treatment before colon surgery 6) In the case of mental retardation or cognitive impairment who cannot make voluntary decisions 7) When other researchers make a decision that participation in the research is inappropriate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Boston bowel preparation scare;Cecal intubation;Insertion time | — |
Secondary
| Measure | Time frame |
|---|---|
| Satisfaction with taking;Compliance;Satisfaction with flavor;Willingness to switch to another bowel preparation drug;Willingness to reuse the same bowel preparation drug;Dosage;Adverse event | — |
Countries
Korea, Republic of
Contacts
Public ContactJin Hwa Park
Asan Medical Center
Outcome results
None listed